Читаем Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний полностью

Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

Бастиан Блоэм , Майкл Окун , Рэй Дорси , Тодд Шерер

61. Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, Ross CA. Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nature Neuroscience. 2006;9(10): 1231–1233; Martin I, Kim JW, Dawson VL, Dawson TM. LRRK2 pathobiology in Parkinson’s disease. Journal of Neurochemistry. 2014;131(5):554–565.

62. Martin I, Kim JW, Dawson VL, Dawson TM. LRRK2 pathobiology in Parkinson’s disease. Journal of Neurochemistry. 2014;131(5):554–565.

63. Moses H, Dorsey ER, Matheson DM, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294(11): 1333–1342; Moses H, Matheson DM, Cairns-Smith S, George BP, Palisch C, Dorsey E. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174–189.

64. Moses H, Dorsey ER, Matheson DM, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294(11):1333–1342.

65. 2018 PhRMA Annual Membership Survey. Pharmaceutical Research and Manufacturers of America. July 26, 2018. www.phrma.org/ report/2018-phrma-annual-membership-survey. Accessed June 28, 2019.

66. Moses H, Dorsey ER, Matheson DM, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294(11): 1333–1342; Moses H, Matheson DM, Cairns-Smith S, George BP, Palisch C, Dorsey E. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174–189.

67. Moses H, Dorsey ER, Matheson DM, Thier SO. Financial anatomy of biomedical research. JAMA. 2005;294(11):1333–1342.

68. Cannon JR, Greenamyre JT. Gene-environment interactions in Parkinson’s disease: specific evidence in humans and mammalian models. Neurobiology of Disease. 2013;57:38–46.

69. Там же.

70. Там же.

71. Di Maio R, Hoffman EK, Rocha EM, et al. LRRK2 activation in idiopathic Parkinson’s disease. Science Translational Medicine. 2018; 10(451); Cannon JR, Greenamyre JT. Gene-environment interactions in Parkinson’s disease: specific evidence in humans and mammalian models. Neurobiology of Disease. 2013;57:38–46; Lee J-W, Cannon JR. LRRK2 mutations and neurotoxicant susceptibility. Experimental Biology and Medicine. 2015;240(6):752–759.

72. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry. 1992;55(3):181–184; Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. 2016;86(6):566–576.

73. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry. 1992;55(3):181–184; Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson’s disease in the community? Journal of Neurology, Neurosurgery & Psychiatry. 2002;73(5):529.

74. Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology. 2016;86(6):566–576.

75. MDS-UPDRS. International Parkinson and Movement Disorder Society. July 1, 2008. www.movementdisorders.org/MDS-Files1/PDFs/Rating-Scales/MDS-UPDRS_English_FINAL_Updated_June2019.pdf.

76. Dolan KA. Andy Grove’s last stand. Forbes. January 11, 2008. www. forbes.com/forbes/ 2008/0128/070.html#462dbe0b641e. Accessed June 28, 2019.

77. Little MA, McSharry PE, Roberts SJ, Costello DA, Moroz IM. Exploiting nonlinear recurrence and fractal scaling properties for voice disorder detection. BioMedical Engineering OnLine. 2007;6(1):23.

78. Little MA, McSharry PE, Hunter EJ, Spielman J, Ramig LO. Suitability of dysphonia measurements for telemonitoring of Parkinson’s disease. IEEE Transactions on Biomedical Engineering. 2009;56(4):1015–1022.

79. Tsanas A, Little MA, McSharry PE, Spielman J, Ramig LO. Novel speech signal processing algorithms for high-accuracy classification of Parkinson’s disease. IEEE Transactions on Biomedical Engineering. 2012;59(5):1264–1271.

Перейти на страницу: